GLP-1 Side Effects: Which Ones Are Normal and Which Ones Mean Call Your Doctor
From everyday nausea to pancreatitis warning signs — a clear breakdown of what to ride out and what to report.
All sources locked in. Writing the article now.
Most people on a GLP-1 feel something in the first few weeks. The question isn't whether side effects happen — it's which ones you ride out and which ones you actually call about.
Here's a clear-eyed breakdown, grounded in the FDA labels and published research, so you know what's normal, what's annoying-but-manageable, and what's a genuine reason to pick up the phone.
The Everyday Side Effects (Yes, They're Real — and Usually Temporary)
Both the FDA label for Wegovy (semaglutide) and the FDA label for Zepbound (tirzepatide) list the same short-list of common reactions — meaning they showed up in at least 5% of people in clinical trials. That list includes: nausea, diarrhea, vomiting, constipation, abdominal pain, fatigue, and heartburn (GERD).
These drugs slow down how fast your stomach empties. That's partly why they work — you feel full faster, eat less. But your gut notices the change, especially in the first few weeks after a dose increase.
A 2024 review in Obesity Pillars on GLP-1 agonists for obesity: weight loss outcomes, tolerability, side effects, and risks confirms that GI symptoms are the most frequently reported adverse effects across this drug class, and they tend to peak around dose escalation windows before improving.
What helps: Eating smaller meals, avoiding high-fat or spicy foods around injection day, staying upright after eating, and going slow on dose increases if your prescriber allows it. These are management strategies — not medical advice specific to your situation.
The Side Effects Worth Mentioning at Your Next Appointment
Some reactions aren't emergencies but are worth flagging so your prescriber can adjust your plan.
Hair thinning. The Zepbound label specifically lists hair loss as a reported reaction. This is also seen with rapid weight loss in general — not necessarily the drug itself. If you're noticing it, bring it up. It's often temporary but worth tracking.
Fatigue. Both labels list fatigue as a common reaction. If it's severe enough to affect your daily life, that's a conversation to have — it could relate to calorie restriction, not just the medication.
Injection site reactions. Zepbound's label calls these out explicitly. Redness, itching, or small lumps at the injection site are common. Rotating your injection sites usually helps. A persistent lump or spreading redness is worth a call.
Heart rate changes. The Wegovy label includes a specific warning to monitor heart rate at regular intervals because increases have been observed. If you're noticing a consistently elevated pulse — especially at rest — mention it.
The "Call Your Prescriber" Tier
These aren't meant to scare you. They're on the FDA labels because they happened in trials or post-market reports. Knowing the symptoms means you catch them early.
Severe upper abdominal pain that doesn't quit. According to MedlinePlus, severe pain in the upper abdomen — especially with nausea and vomiting — is a hallmark symptom of pancreatitis, which is inflammation of the pancreas. Both the Wegovy and Zepbound FDA labels warn that acute pancreatitis has occurred in clinical trials and instruct patients to discontinue the drug promptly if it's suspected. Don't wait this one out.
Pain in your upper right abdomen, especially after eating. According to MedlinePlus, gallstone attacks often cause pain in the abdomen, back, or just under the right arm, frequently after meals. The FDA labels for both drugs flag acute gallbladder disease as a serious adverse reaction. Rapid weight loss is a known gallstone risk factor on its own — GLP-1 use adds another layer to watch.
Signs of dehydration or decreased urination after severe GI symptoms. Both labels specifically warn about acute kidney injury tied to volume depletion — meaning if you've been vomiting or had significant diarrhea and you're not urinating normally, that's a call (or urgent care visit). A 2021 safety review of semaglutide in Frontiers in Endocrinology underscores that GI-related dehydration is a meaningful pathway to renal stress on these medications.
Allergic reactions. Both labels list anaphylaxis and angioedema (swelling of the face, lips, throat) as post-marketing reports. Hives, difficulty breathing, or throat swelling after an injection = stop the medication and seek emergency care immediately.
Mood changes or thoughts of self-harm. The Wegovy label includes a warning to monitor for depression or suicidal thoughts, and instructs discontinuation if symptoms develop. If you're experiencing either, contact your prescriber or a crisis line — don't wait for your next scheduled appointment.
The Thyroid Warning — What You Actually Need to Know
You've probably seen the black-box warning about thyroid C-cell tumors. Both labels carry it. This was observed in rodent studies, and according to the FDA labels, it's unknown whether GLP-1 drugs cause thyroid tumors in humans. Both drugs are contraindicated if you have a personal or family history of medullary thyroid carcinoma (MTC) or a condition called MEN 2.
If you were cleared for the medication by your prescriber, they already considered this. But if you notice a lump in your neck, hoarseness, or difficulty swallowing, those are symptoms worth reporting.
What This Means for You
- Nausea, loose stools, and fatigue in the first weeks are common — especially after dose increases. They're real and they're annoying, but they usually ease. Small meals and slow eating help more than most people expect.
- Upper abdominal pain that's severe or persistent, signs of dehydration, allergic reactions, or mood changes are "call now" symptoms — not something to manage at home or search the internet about.
- Your prescriber wants to hear from you. These drugs have a titration schedule for a reason — adjusting pace is a normal, valid option. You don't have to white-knuckle through miserable side effects.
Not medical advice. Talk to your prescriber about your specific situation, symptoms, and health history.
